NOVAGYNE

Serial Number 75628748
606

Registration Progress

Application Filed
Jan 27, 1999
Under Examination
Feb 15, 2000
Approved for Publication
Oct 15, 1999
Published for Opposition
Nov 16, 1999
Registered

Trademark Image

NOVAGYNE

Basic Information

Serial Number
75628748
Filing Date
January 27, 1999
Published for Opposition
November 16, 1999
Abandonment Date
August 16, 2003
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Aug 16, 2003
Classes
005

Rights Holder

VIVELLE VENTURES, LLC

03
Address
c/o Noven Pharmaceuticals, Inc.
11960 Southwest 144th Street
Miami, FL 33186

Ownership History

VIVELLE VENTURES, LLC

Original Applicant
03
Miami, FL

VIVELLE VENTURES, LLC

Owner at Publication
03
Miami, FL

Legal Representation

Attorney
CHRIS DONINGER

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

16 events
Date Code Type Description Documents
Sep 15, 2003 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jul 16, 2002 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 7, 2002 EXT4 S SOU EXTENSION 4 FILED Loading...
Jan 7, 2002 EX4G S SOU EXTENSION 4 GRANTED Loading...
Aug 10, 2001 EX3G S SOU EXTENSION 3 GRANTED Loading...
Aug 1, 2001 EXT3 S SOU EXTENSION 3 FILED Loading...
Mar 18, 2001 EX2G S SOU EXTENSION 2 GRANTED Loading...
Feb 15, 2001 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 11, 2000 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 14, 2000 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 15, 2000 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 16, 1999 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 15, 1999 NPUB O NOTICE OF PUBLICATION Loading...
Jul 27, 1999 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 16, 1999 CNEA F EXAMINER'S AMENDMENT MAILED Loading...
Jul 13, 1999 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of hormonal imbalances and deficiencies, pre and post menopausal symptoms and osteoporosis, and women's hormonal and reproductive disorders, ailments and conditions
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005